Please use this identifier to cite or link to this item:
Title: Epstein-Barr viral latent and early antigen serology in nasopharyngeal carcinoma
Authors: Tan, Timothy Ter Ming.
Keywords: DRNTU::Science::Biological sciences::Microbiology::Virology
Issue Date: 1999
Abstract: Nasopharyngeal carcinoma (NPC) is cancer of the nasopharynx in humans. It is an insidious and often rapidly fatal disease that is rare worldwide, but is very common among the Chinese from southern China and south-east Asia. It is difficult to detect since, in its early stages, patients are asymptomatic. However, NPC detected in its early stages is highly curable through radiation therapy. Clinically, it can be detected by an experienced medical practitioner using fibreoptic endoscopy, computer-assisted tomography or through serological tests. Serological testing detects the presence of specific antibodies to the Epstein-Barr virus, which is a crucial aetiological factor in the pathogenesis of the disease. Current methods include detection by indirect immunofluorescence assay which is laborious, subjective and requires highly-trained personnel, and enzyme-linked immunosorbent assay (ELISA), which can be easily performed by any hospital laboratory.
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:NIE Theses

Files in This Item:
File Description SizeFormat 
  Restricted Access
14.43 MBAdobe PDFView/Open
  Restricted Access
30.22 MBAdobe PDFView/Open

Page view(s)

Updated on Oct 26, 2021


Updated on Oct 26, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.